buyWeak
Charles Theuer bought $38k of TCON
President and CEO at Tracon Pharmaceuticals, Inc.. 50,999 shares at an average of $0.74, traded Apr 26, 2023, filed Apr 28, 2023.
Conviction score
39Value
$38k
50,999 shares
Holdings after
399,417
+15% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +6Trade size$38k at market
- +3Relative to holdingsHoldings up 15%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001209191-23-025930, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 26, 2023 | POpen-market purchase Common Stock | +3,999 | $0.66 | $2,639 | 352,417 | Apr 28, 2023 |
| Apr 27, 2023 | POpen-market purchase Common Stock | +47,000 | $0.75 | $35k | 399,417 | Apr 28, 2023 |
Related signals
Other insiders at Tracon Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | TCONsell Tracon Pharmaceuticals, Inc. | Opaleye Management Inc. owner | $1.4M 4,764,008 shares | -110% | |
| 43Moderate | Tracon Pharmaceuticals, Inc. | Opaleye Management Inc. owner | $241k 174,508 shares | +4% | |
| 38Weak | Tracon Pharmaceuticals, Inc. | Charles Theuer President and CEO | $7,600 5,000 shares | +1% | |
| 15Weak | TCONsell Tracon Pharmaceuticals, Inc. | William R Larue director | $151 120 shares | -2% | |
| 30Weak | TCONbuy Tracon Pharmaceuticals, Inc. | Charles Theuer President and CEO | $11k 6,800 shares | +2% | |
| 25Weak | TCONbuy Tracon Pharmaceuticals, Inc. | Scott B. Brown Chief Financial Officer | $5,215 3,500 shares | +19% | |
| 42Moderate | Tracon Pharmaceuticals, Inc. | Opaleye Management Inc. owner | $210k 167,500 shares | +4% | |
| 46Moderate | Tracon Pharmaceuticals, Inc. | Charles Theuer President and CEO | $30k 23,000 shares | +7% | |
| 12Weak | TCONsell Tracon Pharmaceuticals, Inc. | Opaleye Management Inc. owner | $2,216 1,539 shares | -0% | |
| 30Weak | TCONbuy Tracon Pharmaceuticals, Inc. | Charles Theuer President and CEO | $20k 13,900 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.